Literature DB >> 25237939

Characterizing brain mineral deposition in patients with Wilson disease using susceptibility-weighted imaging.

Xiang-Xue Zhou1, Hao-Lin Qin, Xun-Hua Li, Hai-Wei Huang, Ying-Ying Liang, Xiu-Ling Liang, Xiao-Yong Pu.   

Abstract

AIMS: The aim of this study was to evaluate the feasibility of characterizing the brain-mineral deposition in patients with Wilson disease (WD) using susceptibility-weighted imaging (SWI).
MATERIALS AND METHODS: The study enrolled 30 WD patients and 20 age-matched healthy controls. Neurological symptoms were scored using the modified Young Scale. The hepatic function indices, serum and urinary copper content, and serum iron content were determined. All study objects received the magnetic resonance imaging (MRI) and SWI test of the brain. The values of corrected phase (CP) were calculated on SWI. The relationship between CP values and the clinical status were evaluated.
RESULTS: The serum iron content of WD patients was higher than the normal. The CP values of substantia nigra, caudate nucleus, and globus pallidus of WD were lower than the normal values, while the CP value of substantia nigra was the lowest. No correlations were determined between the CP values and the iron and copper parameters. There was negative correlation between the scores of dysarthria and the CP values of the globus pallidus. There was negative correlation between the scores of tremor and the CP values of caudate nucleus. Some regions, which had high signals on T2-weighted image, had low signals on SWI.
CONCLUSIONS: There might be abnormal iron metabolism in patients with WD. The decreased CP values might reflect a deposition of both copper and iron. SWI may be more sensitive than the ordinary MRI. The mineral deposition may contribute to the neural symptoms.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25237939     DOI: 10.4103/0028-3886.141221

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  6 in total

1.  Microstructure changes in whiter matter relate to cognitive impairment in Wilson's disease.

Authors:  Ting Dong; Wen-Ming Yang; Ming-Cai Wu; Juan Zhang; Peng Huang; Chun-Sheng Xu; An-Qin Wang; Chun-Jun Kuang; Zhi-Ling Gao
Journal:  Biosci Rep       Date:  2019-03-15       Impact factor: 3.840

2.  Injury factors and pathological features of toxic milk mice during different disease stages.

Authors:  Xiang-Xue Zhou; Xun-Hua Li; Ding-Bang Chen; Chao Wu; Li Feng; Hao-Lin Qin; Xiao-Yong Pu; Xiu-Ling Liang
Journal:  Brain Behav       Date:  2019-11-19       Impact factor: 2.708

Review 3.  An Updated Overview of the Magnetic Resonance Imaging of Brain Iron in Movement Disorders.

Authors:  Nicola Tambasco; Pasquale Nigro; Andrea Chiappiniello; Federico Paolini Paoletti; Sara Scialpi; Simone Simoni; Pietro Chiarini; Lucilla Parnetti
Journal:  Behav Neurol       Date:  2022-02-24       Impact factor: 3.342

4.  Brain iron deposition analysis using susceptibility weighted imaging and its association with body iron level in patients with mild cognitive impairment.

Authors:  Lili Gao; Zhihong Jiang; Zhaocheng Cai; Ming Cai; Qing Zhang; Yingying Ma; Guoliang Li; Fengzhu Zhao; Qiang Ma
Journal:  Mol Med Rep       Date:  2017-09-29       Impact factor: 2.952

5.  Magnetic Susceptibility Changes in the Basal Ganglia and Brain Stem of Patients with Wilson's Disease: Evaluation with Quantitative Susceptibility Mapping.

Authors:  Selim Doganay; Kazim Gumus; Gonca Koc; Ayse Kacar Bayram; Mehmet Sait Dogan; Duran Arslan; Hakan Gumus; Sureyya Burcu Gorkem; Saliha Ciraci; Halil Ibrahim Serin; Abdulhakim Coskun
Journal:  Magn Reson Med Sci       Date:  2017-05-18       Impact factor: 2.471

6.  Neuroimaging correlates of brain injury in Wilson's disease: a multimodal, whole-brain MRI study.

Authors:  Samuel Shribman; Martina Bocchetta; Carole H Sudre; Julio Acosta-Cabronero; Maggie Burrows; Paul Cook; David L Thomas; Godfrey T Gillett; Emmanuel A Tsochatzis; Oliver Bandmann; Jonathan D Rohrer; Thomas T Warner
Journal:  Brain       Date:  2022-03-29       Impact factor: 13.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.